Serina Therapeutics, Inc.
SER- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001708599
In the last 90 days, Serina Therapeutics, Inc. insiders filed 1 open-market purchase and 0 sales; 27 institutions reported holding it in 13F filings for Q2 2026, worth $2.73M in total; no superinvestor holds it.
Q4 2023 vs. Q3 2023
How the institutions holding Serina Therapeutics, Inc. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Q4 2023 | Change |
|---|---|---|---|
| Holders | 30 | 35 | +5 |
| Shares | 4.83M | 4.97M | +141.9K (+2.9%) |
| Value | $3.29M | $1.91M | −$1.37M (−41.8%) |
New holders (6)
Institutions that held Serina Therapeutics, Inc. at the end of Q4 2023 but not at the end of Q3 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Virtu Financial LLC | 28,712 | $11.0K | 0.00% |
| Citadel Advisors LLC | 21,448 | $8.26K | 0.00% |
| Jane Street Group, LLC | 11,542 | $4.44K | 0.00% |
| Advisory Services Network, LLC | 500 | $193 | 0.00% |
| Bank of America Corp | 26 | $10 | 0.00% |
| Planning Capital Management Corp | 10 | $4 | 0.00% |
Sold out (1)
Institutions that held Serina Therapeutics, Inc. at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| Capital Advisors, Ltd. LLC | 22 | $0 |